prevalent primary malignant tumors and accounts for about 90% of all primary liver cancers. HBV is the main causative agent in the high incidence HCC areas, HCV is the major etiological factor in low incidence HCC areas, like Western Europe and North America. 3 The rate of HCC progression varies greatly among patients with chronic HCV infection, and this is probably due to the existence of a complex interplay between host, viral, and environmental factors. 4 At present, the positive rate of HCV cAg in serum qualitatively tested by ELISA is low and its sensitivity is lower than HCV The antibodies to HCV (anti-HCV) are at present the most commonly available marker of HCV infection, but the most important indicator of HCV diffusion seems to be its classification into different genetic variants. 1 At present, the antiviral therapies of HCV China covered all the six genotypes. 5 The main prevalent subgenotype was 1b, followed by 2a. HCV RNA was correlated with HCV cAg without consideration of HCV genotype. [6] [7] [8] The HCV RNA expression level reflected that viral replication activity was closely related to liver inflammation degree, prognosis, and antiviral treatment. 9 As the best supplementary indicator for HCV antibody detection, HCV cAg could be a diagnostic indicator for early HCV infection. HCV cAg was detectable for 12-70 days after HCV infection. After 70 days, HCV cAg disappeared and HCV antibody was produced. The study was aimed at determining whether HCV cAg can be an early indicator for supplementary diagnosis of HCV infection by analyzing the correlation between HCV RNA load and HCV cAg of different HCV genotypes. 
| MATERIAL S AND ME THODS

| Study subjects
| HCV cAg qualitative test
The ELISA was used in the test according to specification of HCV Core Antigen Diagnostic Kit (Shandong Laibo Bio-chemical Co.
Ltd., Jinan City, China). Measured the OD value of each sample with TECAN Microplate Reader (Austria) to test HCV cAg (dualwavelength was 450 nm/630-690 nm, Cut-off value=0.12).
| HCV cAg quantitative test
HCV cAg was tested by CMIA according to specifications of HCV Core Antigen Diagnostic Kit (Abbott Laboratories, Chicago, IL, USA) and i2000 Automatic Chemiluminescence Analyzer (Abbott Laboratories, USA). When the sample concentration ≥3.00 fmol/L, the sample was considered to be reactive in the detection of HCV cAg. The specificity of HCV Ag assay is ≥99.5%, and the sensitivity is 97.8%.
| Statistical analysis
Continuous variables were summarized as median (the inter-quartile range):M(P25,P75) and categorical variables as frequency (percentage).
Comparisons between groups were performed using the KruskalWallis H test for continuous variables, and the χ 2 test for categorical data. Spearman's rank correlation was used for correlation analysis.
Comparisons between different groups were performed using analysis of variance. All P values were based on a two-sided test of statistical significance. Significance was accepted at P < 0.05. All analyses were performed with SPSS software for windows, version 17.0 (SPSS Inc., Chicago, IL, USA).
| RE SULTS
| General clinical characteristics
Among 106 HCV-infected patients, the levels of HCV RNA, HCV cAg, ALT, and AST were expressed as medians (the inter-quartile range): M(P25,P75), shown as in Table 1 . 
| HCV genotype distribution
| The positive rates of HCV cAg detected by CMIA and ELISA
Among 106 HCV-infected patients, the positive rates of HCV cAg detected by CMIA and ELISA were 100% and 56%, respectively, which were statistically significant (χ 2 = 60.38, P = 0.000). Among 1b genotype, the positive rates of HCV cAg were 100% (detected by CMIA) and 63% (detected by ELISA), with statistical significance (χ 2 = 20.85, P = 0.000). Among 3a genotype, the positive rates of HCV cAg were 100% (by CMIA) and 61% (by ELISA), which was statistically significant (χ 2 = 8.69, P = 0.008). Among 6a genotype, the positive rates of HCV cAg were 100% (by CMIA) and 44% (by ELISA), which was statistically significant (χ 2 = 6.92, P = 0.009). Among 1b/3b mixed genotype, the positive rates of HCV cAg were 100%
(by CMIA) and 61% (by ELISA), with statistical significance (χ 2 = 7.80, P = 0.015). Among unidentified genotype, the positive rates of HCV cAg were 100% (by CMIA) and 30% (by ELISA), which were statistically significant (χ 2 = 10.77, P = 0.003). There was no statistical significance in positive rates of HCV cAg detected by CMIA and ELISA among other subgenotypes (P > 0.05; See Table 3 ).
| Comparison of expression levels of HCV RNA, HCV cAg, ALT, and AST in different genotypes
The levels of HCV RNA, HCV cAg, ALT, and AST in different genotypes were compared as following: the level of HCV cAg in 1b genotype was higher than that in 3b genotype and 1b/3b mixed genotype, with statistical significance (U = 3.0, P = 0.006, U = 165, P = 0.014).
However, there was no statistical significance in the levels of HCV RNA, ALT, and AST (P > 0.05). Among other genotypes, expression levels of HCV RNA, HCV cAg, ALT, and AST were not statistically significant (P > 0.05; See Table 4 ).
| Correlation analysis between HCV RNA load and HCV cAg in different genotypes
The correlation between HCV RNA load and HCV cAg in different Table 5 ). viremia and elevated ALT levels. HCV RNA is usually detected earlier than anti-HCV after acute HCV infection.
| D ISCUSS I ON
HCV RNA becomes detectable within 2 weeks after exposure to HCV. HCV cAg can be detected in 1-2 days after appearance of HCV RNA, while anti-HCV cannot be detected until 8-12 weeks after infection.
HCV can be divided into six genotypes (from 1 to 6) according to the difference of nucleotide sequences, and each genotype has several subtypes which are represented by a, b, c. The geographic distribution of HCV genotypes is rather complex. The so-called epidemic subtypes-specifically 1a, 1b, 2a, and 3a-are widely distributed worldwide and account for a great proportion of the totality of HCV cases, especially in high income countries. 1, 12 There are regional differences in distribution of genotypes, and genotype 1 is the most widely distributed around the world. In China, the most common HCV infection genotype is 1b, followed by 2a. 13 The gen- *P = 0.000; **P = 0.008; ***P = 0.009; ****P = 0.015. In this study, the positive rates of HCV cAg were detected by CMIA (100%) and ELISA (56%), which shows the former higher than the latter (χ 2 = 60.38, P = 0.000). The reason why the positive rate detected by CMIA was higher than that of ELISA was that ELISA could only detect free HCV cAg, while CMIA had a lower detection limit than ELISA and it could quantitatively test HCV cAg, including free HCV cAg and compounds of free HCV cAg and HCV-Ab, which greatly improved sensitivity of HCV cAg detection. 20 Quantitatively test HCV cAg with CMIA in HCV infection diagnosis had advantages, such as high positive rate, good specificity and sensitivity, short window period, and easy operation. In conclusion, HCV core antigen detection and quantification thus represent a valuable alternative to HCV RNA testing for diagnosing HCV infection in genotype 1b. This is particularly interesting for low resource countries, because HCV RNA measurements need well equipped and specialized laboratories, and are quite expensive. HCV cAg could be an early detection indicator to support HCV infection diagnosis, and it also reflected level of virus replication. Despite our data suggest the association exist between HCV cAg and HCV RNA in genotype 1b,a prospective study with larger number of samples will be needed to confirm our results, especially considering the strict correlation existing between Genotype 1b and HCV Ag. 
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